Outcomes of Malaysian patients with advanced lung adenocarcinoma and unknown epidermal growth factor receptor mutation status treated with gefitinib

Liam CK; Ruthranesan M; Lee CH; Pang YK; Chua KT; Lim BK

doi:10.1111/j.1743-7563.2011.01509.x

Outcomes of Malaysian patients with advanced lung adenocarcinoma and unknown epidermal growth factor receptor mutation status treated with gefitinib

Liam CK , Ruthranesan M , Lee CH , Pang YK , Chua KT , Lim BK

Asia Pac J Clin Oncol, 2012 Sep;8(3):267-74.

PMID: 22897510 DOI: 10.1111/j.1743-7563.2011.01509.x

Abstract

To evaluate the response and progression-free survival (PFS) of Malaysian patients with advanced lung adenocarcinoma and unknown epidermal growth factor receptor (EGFR) mutation status treated with gefitinib.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.